Smith E M, Hughes T K, Blalock J E
Infect Immun. 1983 Jan;39(1):220-4. doi: 10.1128/iai.39.1.220-224.1983.
Nonsensitized human and mouse lymphocytes produce interferon (IFN)-alpha and IFN-alpha/beta, respectively, in response to most transformed cells, as well as normal xenogeneic cells. The treatment of transformed human (WISH) and mouse (L) or normal mouse embryo (ME) cells with trypsin, pepsin, or neuraminidase resulted in a loss of the cell's ability to induce IFN-alpha or alpha/beta. These findings suggested that a cell surface glycoprotein is responsible for the induction of IFN-alpha and alpha/beta. The sonication of WISH, L, and ME cells released glycoproteins which retained IFN-inducing activity in the soluble form. The inducing molecules from WISH, L, and ME cells had molecular weights of 130,000, 90,000, and 68,000, respectively. Further purification, plus a confirmation of the glycoprotein nature of the inducer molecule, was shown by specifically binding and eluting L cell inducer bioactivity from a concanavalin A-Sepharose affinity column.
未致敏的人类和小鼠淋巴细胞分别对大多数转化细胞以及正常异种细胞产生α干扰素(IFN-α)和α/β干扰素(IFN-α/β)。用胰蛋白酶、胃蛋白酶或神经氨酸酶处理转化的人类细胞(WISH)、小鼠细胞(L)或正常小鼠胚胎细胞(ME),会导致细胞诱导IFN-α或α/β的能力丧失。这些发现表明,一种细胞表面糖蛋白负责诱导IFN-α和α/β。对WISH、L和ME细胞进行超声处理后释放出糖蛋白,这些糖蛋白以可溶形式保留了IFN诱导活性。来自WISH、L和ME细胞的诱导分子的分子量分别为130,000、90,000和68,000。通过从伴刀豆球蛋白A-琼脂糖亲和柱上特异性结合并洗脱L细胞诱导剂生物活性,进一步证明了诱导分子的糖蛋白性质并对其进行了纯化。